text
stringlengths
81
4.38k
<s>[INST] Provide the medical condition for trial id: NCT01879189 [/INST] Breast Cancer </s>
<s>Trial Id: Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device Recruitment Status: Unknown status Trail description: Circulating tumor cells (CTCs) in peripheral blood originate from breast cancer (primary and metastatic lesions) shedding. Utilization of...
<s>[INST] Provide inclusion criteria for trial id: NCT04239105 [/INST] All subjects need to sign the informed consent form. Age of at least 20 and at most 70 years. Cancer group subjects with pathology report confirmed to be malignant. Chemotherapy is necessary before or after surgery. Control group need to have mammo...
<s>[INST] Provide exclusion criteria for trial id: NCT04239105 [/INST] Not willing to sign the informed consent form. Pregnant or lactating patients. Prior or concomitant secondary malignancy. Any other serious medical pathology, such as congestive heart failure. Other condition which may affect the CTC results. Males...
<s>[INST] Provide description for trial id: NCT04239105 [/INST] Circulating tumor cells (CTCs) in peripheral blood originate from breast cancer (primary and metastatic lesions) shedding. Utilization of CTCs as novel and noninvasive tests for diagnosis confirmation, therapy selection, and cancer surveillance is a rapid...
<s>[INST] Provide title for trial id: NCT04239105 [/INST] Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device </s>
<s>[INST] Provide the recruitment status for trial id: NCT04239105 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT04239105 [/INST] Breast Neoplasms, Circulating Tumor Cells </s>
<s>Trial Id: Mobile Application Support for Women With Breast Cancer Undergoing Chemotherapy Recruitment Status: Recruiting Trail description: Mobile phones have become an essential tool for everyday life. The convenience and easy accessibility of the data and information received through mobile phones have made mobile...
<s>[INST] Provide inclusion criteria for trial id: NCT05072197 [/INST] at least 20 years of age. diagnosed with breast cancer for the first time. treated with chemotherapy at the study sites. able to access the internet with a mobile phone. Fluent in spoken and written Chinese . </s>
<s>[INST] Provide exclusion criteria for trial id: NCT05072197 [/INST] patients with cognitive dysfunction. diagnosed mental health problems. having with other cancers. </s>
<s>[INST] Provide description for trial id: NCT05072197 [/INST] Mobile phones have become an essential tool for everyday life. The convenience and easy accessibility of the data and information received through mobile phones have made mobile applications as the latest trend to provide education for patients in medical...
<s>[INST] Provide title for trial id: NCT05072197 [/INST] Mobile Application Support for Women With Breast Cancer Undergoing Chemotherapy </s>
<s>[INST] Provide the recruitment status for trial id: NCT05072197 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT05072197 [/INST] Breast Neoplasms </s>
<s>Trial Id: Breast Cancer Proteomics and Molecular Heterogeneity Recruitment Status: Recruiting Trail description: Primary objective: The primary objective is to define the proteomic and molecular characteristics of primary and recurrent/ metastatic breast tumours with special focus on the expression of S100 protein ...
<s>[INST] Provide inclusion criteria for trial id: NCT01840293 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT01840293 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT01840293 [/INST] Primary objective: The primary objective is to define the proteomic and molecular characteristics of primary and recurrent/ metastatic breast tumours with special focus on the expression of S100 protein and the estrogen receptor (ER), progesterone recept...
<s>[INST] Provide title for trial id: NCT01840293 [/INST] Breast Cancer Proteomics and Molecular Heterogeneity </s>
<s>[INST] Provide the recruitment status for trial id: NCT01840293 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT01840293 [/INST] Primary Breast Cancer, Recurrent/Metastatic Breast Cancer </s>
<s>Trial Id: Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. Recruitment Status: Completed Trail description: Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating cancer cell/macrophage hybrid cells in the peripheral blood. The study will be c...
<s>[INST] Provide inclusion criteria for trial id: NCT04818125 [/INST] Patient with breast cancer of any stage (stage I, II, III or IV) and any immunohistochemical subtype (triple-negative, HR+/HER2-negative or HER2-positive). Patient not yet initiated on specific treatment for the stage of breast cancer at inclusion....
<s>[INST] Provide exclusion criteria for trial id: NCT04818125 [/INST] Associated pathology(ies) that may prevent the proper conduct of the procedure under consideration. Pregnant or breastfeeding woman. Any psychological, family, geographical or sociological condition that prevents compliance with the medical follow-...
<s>[INST] Provide description for trial id: NCT04818125 [/INST] Pilot, prospective, monocentric study aimed at evaluating the rate of patients with circulating cancer cell/macrophage hybrid cells in the peripheral blood. The study will be conducted on a population of patients with breast cancer (regardless of stage o...
<s>[INST] Provide title for trial id: NCT04818125 [/INST] Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer. </s>
<s>[INST] Provide the recruitment status for trial id: NCT04818125 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT04818125 [/INST] Breast Cancer </s>
<s>Trial Id: Blood Glycan Biomarkers in Women With Stage IV Breast Cancer Recruitment Status: Completed Trail description: RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This resea...
<s>[INST] Provide inclusion criteria for trial id: NCT00897962 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT00897962 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT00897962 [/INST] RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood glycan biomarkers in women w...
<s>[INST] Provide title for trial id: NCT00897962 [/INST] Blood Glycan Biomarkers in Women With Stage IV Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT00897962 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT00897962 [/INST] Breast Cancer </s>
<s>Trial Id: Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics Recruitment Status: Completed Trail description: RATIONALE: Diagnostic procedures, such as dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI), magnetic resonance spectroscopy (MRS), and tissue proteomics, may help docto...
<s>[INST] Provide inclusion criteria for trial id: NCT00656604 [/INST] None </s>
<s>[INST] Provide exclusion criteria for trial id: NCT00656604 [/INST] None </s>
<s>[INST] Provide description for trial id: NCT00656604 [/INST] RATIONALE: Diagnostic procedures, such as dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI), magnetic resonance spectroscopy (MRS), and tissue proteomics, may help doctors find and diagnose breast cancer and plan the best treatment. PURPOSE: ...
<s>[INST] Provide title for trial id: NCT00656604 [/INST] Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics </s>
<s>[INST] Provide the recruitment status for trial id: NCT00656604 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT00656604 [/INST] Breast Cancer </s>
<s>Trial Id: Awareness Scale Related To Physiotherapy After Breast Cancer: A Scale Development Study Recruitment Status: Recruiting Trail description: In this study, the aim is to develop a scale that assesses the awareness levels of particularly short and/or long-term effects, especially related to physiotherapy, in i...
<s>[INST] Provide inclusion criteria for trial id: NCT05992441 [/INST] Be over 18 years old Be woman Being diagnosed with breast cancer (individuals diagnosed with breast cancer who will start, start or have completed breast cancer treatment) Being able to read and understand the Turkish language </s>
<s>[INST] Provide exclusion criteria for trial id: NCT05992441 [/INST] Having a cognitive impairment that interferes with answering questions Be man </s>
<s>[INST] Provide description for trial id: NCT05992441 [/INST] In this study, the aim is to develop a scale that assesses the awareness levels of particularly short and/or long-term effects, especially related to physiotherapy, in individuals diagnosed with high incidence and survival rates of breast cancer. </s>
<s>[INST] Provide title for trial id: NCT05992441 [/INST] Awareness Scale Related To Physiotherapy After Breast Cancer: A Scale Development Study </s>
<s>[INST] Provide the recruitment status for trial id: NCT05992441 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT05992441 [/INST] Breast Cancer </s>
<s>Trial Id: Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis Recruitment Status: Unknown status Trail description: Primary purpose : To develop a method to automatically extract and structure the information included in numerous medical records from breast cancer patients. Second...
<s>[INST] Provide inclusion criteria for trial id: NCT02810093 [/INST] Majority (age > 18) Malignant breast tumors signed informed consent </s>
<s>[INST] Provide exclusion criteria for trial id: NCT02810093 [/INST] Benign breast pathology Patients not initially treated at the Hôpitaux Universitaires de Strasbourg </s>
<s>[INST] Provide description for trial id: NCT02810093 [/INST] Primary purpose : To develop a method to automatically extract and structure the information included in numerous medical records from breast cancer patients. Secondary purpose : With this procedure we can analyze the content of ten thousand anonymized...
<s>[INST] Provide title for trial id: NCT02810093 [/INST] Big Data and Text-mining Technologies Applied for Breast Cancer Medical Data Analysis </s>
<s>[INST] Provide the recruitment status for trial id: NCT02810093 [/INST] Unknown status </s>
<s>[INST] Provide the medical condition for trial id: NCT02810093 [/INST] Breast Cancer </s>
<s>Trial Id: Prognostic and Predictive Factors for Small Breast Tumors Recruitment Status: Completed Trail description: Because of mammography screening increasingly more women are diagnosed with centimeter or subcentimeter node-negative breast cancer (i.e., T1abN0); these tumors account for approximately 19% of all ne...
<s>[INST] Provide inclusion criteria for trial id: NCT03390608 [/INST] Female. Operated for centimeter or subcentimeter breast cancer. </s>
<s>[INST] Provide exclusion criteria for trial id: NCT03390608 [/INST] Previous breast cancer. Metastatic breast cancer at diagnosis. </s>
<s>[INST] Provide description for trial id: NCT03390608 [/INST] Because of mammography screening increasingly more women are diagnosed with centimeter or subcentimeter node-negative breast cancer (i.e., T1abN0); these tumors account for approximately 19% of all newly diagnosed breast cancers in Sweden. Although the lo...
<s>[INST] Provide title for trial id: NCT03390608 [/INST] Prognostic and Predictive Factors for Small Breast Tumors </s>
<s>[INST] Provide the recruitment status for trial id: NCT03390608 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT03390608 [/INST] Breast Cancer </s>
<s>Trial Id: Breast Cancer Molecular Analysis Protocol Recruitment Status: Completed Trail description: This is a molecular testing study for patients with metastatic breast cancer. The purpose of this study is to find defects in the DNA of the cancer that could potentially be treated with US Food and Drug Administrati...
<s>[INST] Provide inclusion criteria for trial id: NCT01855503 [/INST] All patients with metastatic breast cancer who are considered for further systemic therapy are eligible regardless of number of prior therapies. Patient must have a metastatic lesion that could be safely biopsied with or without image-guidance. The...
<s>[INST] Provide exclusion criteria for trial id: NCT01855503 [/INST] 1. Known medical contraindication for needle biopsy procedure such as bleeding disorder, low platelet count, inability to provide informed consent </s>
<s>[INST] Provide description for trial id: NCT01855503 [/INST] This is a molecular testing study for patients with metastatic breast cancer. The purpose of this study is to find defects in the DNA of the cancer that could potentially be treated with US Food and Drug Administration (FDA)approved or investigational dru...
<s>[INST] Provide title for trial id: NCT01855503 [/INST] Breast Cancer Molecular Analysis Protocol </s>
<s>[INST] Provide the recruitment status for trial id: NCT01855503 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT01855503 [/INST] Metastatic Breast Cancer </s>
<s>Trial Id: Breast Cancer and Breast Self-examination Education Recruitment Status: Recruiting Trail description: According to a news published by the World Health Organization (WHO); More than 2.3 million cases of breast cancer occur each year, making it the most common cancer among adults. In 95% of all countries, b...
<s>[INST] Provide inclusion criteria for trial id: NCT06371508 [/INST] Able to read and write, Having no history of breast cancer, No communication barriers, Not pregnant or lactating, Those who are willing and agree to participate in the research. </s>
<s>[INST] Provide exclusion criteria for trial id: NCT06371508 [/INST] Having a mental illness, Those who wish to withdraw from any part of the research. </s>
<s>[INST] Provide description for trial id: NCT06371508 [/INST] According to a news published by the World Health Organization (WHO); More than 2.3 million cases of breast cancer occur each year, making it the most common cancer among adults. In 95% of all countries, breast cancer is the first or second cause of femal...
<s>[INST] Provide title for trial id: NCT06371508 [/INST] Breast Cancer and Breast Self-examination Education </s>
<s>[INST] Provide the recruitment status for trial id: NCT06371508 [/INST] Recruiting </s>
<s>[INST] Provide the medical condition for trial id: NCT06371508 [/INST] Breast Cancer, Breast Self-Examination </s>
<s>Trial Id: Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer Recruitment Status: Completed Trail description: In this prospective study the investigators sought to evaluate the feasibility of using the genomic signature - Genomic Grade Index (GGI) - in...
<s>[INST] Provide inclusion criteria for trial id: NCT01916837 [/INST] Histologically confirmed invasive breast cancer meeting the following criteria: T1, T2, or operable T3 disease Zero to three positive lymph nodes and no distant metastases Operable disease - Must have undergone breast-conserving surgery or mastect...
<s>[INST] Provide exclusion criteria for trial id: NCT01916837 [/INST] No other invasive cancer within the past 5 years except for adequately treated carcinoma in situ of the cervix or non melanoma skin cancer No psychological, familial, sociological, or geographical condition that would preclude entering into a clini...
<s>[INST] Provide description for trial id: NCT01916837 [/INST] In this prospective study the investigators sought to evaluate the feasibility of using the genomic signature - Genomic Grade Index (GGI) - in routine clinical practice and its impact on treatment recommendations. </s>
<s>[INST] Provide title for trial id: NCT01916837 [/INST] Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT01916837 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT01916837 [/INST] Invasive Breast Cancer </s>
<s>Trial Id: Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software Recruitment Status: Completed Trail description: Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the grou...
<s>[INST] Provide inclusion criteria for trial id: NCT04980989 [/INST] Adult patients with early breast cancer after primary treatment including also radiotherapy (the patients were randomized at the final visit of radiotherapy) </s>
<s>[INST] Provide exclusion criteria for trial id: NCT04980989 [/INST] not able to use a computer another malignancy </s>
<s>[INST] Provide description for trial id: NCT04980989 [/INST] Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. At 12 months the patients were asked ...
<s>[INST] Provide title for trial id: NCT04980989 [/INST] Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software </s>
<s>[INST] Provide the recruitment status for trial id: NCT04980989 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT04980989 [/INST] Breast Cancer, Early-Onset </s>
<s>Trial Id: The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer Recruitment Status: Completed Trail description: Background: The Dutch guideline on breast cancer treatment shows severa...
<s>[INST] Provide inclusion criteria for trial id: NCT02934126 [/INST] 2-3 months after facing decision or > 1 year after decision able to speak and understand Dutch Written informed consent </s>
<s>[INST] Provide exclusion criteria for trial id: NCT02934126 [/INST] recurrence of breast cancer prior to interview </s>
<s>[INST] Provide description for trial id: NCT02934126 [/INST] Background: The Dutch guideline on breast cancer treatment shows several grey areas, where no clear recommendation is given on the radiotherapy options, but where the advice is to discuss the treatment of choice with the patient. Currently, patients are e...
<s>[INST] Provide title for trial id: NCT02934126 [/INST] The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer </s>
<s>[INST] Provide the recruitment status for trial id: NCT02934126 [/INST] Completed </s>
<s>[INST] Provide the medical condition for trial id: NCT02934126 [/INST] Breast Cancer </s>
<s>Trial Id: Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy Women Recruitment Status: Completed Trail description: RATIONALE: Education, based on a patient's risk factors, may help promote breast cancer screening in healthy women. PURPOSE: This randomized clinical trial is studying...